Abstract:Background and objectiveTriptolide, a type of diterpenoid, is the active compound of Tripterygium wilfordii; it plays roles in anti-inflammatory and immune response regulation. Our objective was to investigate the mechanism of the inhibitory effect of triptolide on interleukin-13 (IL-13) gene expression in activated T lymphocytes. Understanding the molecular mechanism by which triptolide exerts a therapeutic function may be useful in developing a pharmaceutical treatment for asthma.MethodsPeripheral blood mononuclear cells (PBMC) and Hut-78 cells were stimulated with anti-CD3/CD28 with or without co-incubation with triptolide. The alteration of IL-13 messenger RNA (mRNA), expression and protein level were analysed using real-time reverse transcription polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay, respectively. The intracellular distribution profile of transcription factor GATA3 and nuclear factor of activated T cells (NFAT1) were analysed by Western blotting. The binding rates of GATA3 and NFAT1 to the promoter sequence of IL-13 were analysed by chromatin immunoprecipitation (ChIP) PCR.ResultsIn PBMC, the release of IL-13 was dependent on anti-CD3/CD28 stimulation. Its release could be inhibited by triptolide at the concentration of 500nmol. In Hut-78 cells, IL-13 mRNA and protein expression were increased with anti-CD3/CD28 stimulation and significantly inhibited by incubation with 28nmol triptolide. This concentration of triptolide also significantly inhibited the nuclear translocation of GATA3 and NFAT1 reducing the binding rate to the IL-13 gene promoter.ConclusionsTriptolide inhibits IL-13 gene transcription and protein expression by inhibiting GATA3 and NFAT1 nuclear translocation and their binding rates to the IL-13 gene promoter region.

Studies on the Immunosuppression of Triptolide

Modulatory Effect of Triptolide on Differentiation of Human Th17 Cells

Triptolide affects the differentiation, maturation and function of human dendritic cells.

Triptolide Inhibits Donor-Specific Antibody Production and Attenuates Mixed Antibody-Mediated Renal Allograft Injury.

Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways

Immunosuppressive effects of triptolide via interleukin-2/receptor signaling

[The Effects of Triptolide Inhibition of Mouse Lymphocytes Activated in Vitro].

Triptolide Suppresses CD80 and CD86 Expressions and IL-12 Production in THP-1 Cells1

Immunosuppression of triptolide on skin allograft in mice

Effects of Tripterine on the Immunosuppression Action and Expression of IL-6 Mrna in Mice

Pharmacokinetic Study of Triptolide, a Constituent of Immunosuppressive Chinese Herb Medicine, in Rats.

Triptolide Suppresses T-lymphocyte Proliferation by Inhibiting Interleukin-2 Receptor Expression, but Spares Interleukin-2 Production and Mrna Expression.

Triptolide inhibits IL-12 production and T cell-stimulatory capacity of dendritic cells

Triptolide is a Potent Suppressant of C3, CD40 and B7h Expression in Activated Human Proximal Tubular Epithelial Cells

Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-kappaB activation.

Immunosuppressive effect and mechanism of Triptolide on skin allografts in mice

A Study of Microemulsion Systems for Transdermal Delivery of Triptolide.

Immunosuppressant triptolide inhibits dendritic cell-mediated chemoattraction of neutrophils and T cells through inhibiting Stat3 phosphorylation and NF-κB activation

Therapeutic potential of triptolide in autoimmune diseases and strategies to reduce its toxicity

Inhibition of Interleukin-13 Gene Expression by Triptolide in Activated T Lymphocytes

[Effect of Triptolide on Th17/Treg Cells in Spleen].